New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Bolt Biotherapeutics, Inc. (BOLT) vs BioStem Technologies, Inc. (BSEM)
- Bolt Biotherapeutics, Inc. BOLT 4.91 −2.96%
- BioStem Technologies, Inc. BSEM 0.64 −9.86%
Bolt Biotherapeutics, Inc. and BioStem Technologies, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and BioStem Technologies, Inc. are of similar size ($13.6M and $13.2M). Bolt Biotherapeutics, Inc. grew revenue faster over the last twelve months: 12.8% against −83.9%. BioStem Technologies, Inc. has the higher net margin (−121.0% vs −611.5%) and the higher return on invested capital (−7.07% vs −154.8%). Across the 12 metrics below, BioStem Technologies, Inc. leads on 7 and Bolt Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | BOLT | BSEM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 79.83% | 70.18% |
| Operating margin | (654.53%) | (6.18%) | 0.00% |
| Net margin | (611.47%) | (121.02%) | 0.00% |
| Free cash flow margin | (655.72%) | — | 0.00% |
| Return on equity | (127.96%) | — | (51.58%) |
| Return on assets | (51.70%) | — | (45.91%) |
| Return on invested capital | (154.77%) | (7.07%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack